-
1
-
-
0031717677
-
Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12 years experience in more than 900 patients
-
BLITZER A, BRIN MF, STEWART CF. (1998). Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12 years experience in more than 900 patients. Laryngoscope, 108: 1435-41.
-
(1998)
Laryngoscope
, vol.108
, pp. 1435-1441
-
-
Blitzer, A.1
Brin, M.F.2
Stewart, C.F.3
-
2
-
-
18544404206
-
Botulinum toxin treatment for spasmodic dysphonia; percutaneous versus transoral approach
-
GARCIA RUIZ PJ, CENJOR ESPANOL C, SANCHEZ BERNADOS V, ASTARLOA R, SANABRIA J, Garcia de Yebennes J. (1998). Botulinum toxin treatment for spasmodic dysphonia; percutaneous versus transoral approach, Clin. Neuropharmacolgy, 21: 196-8
-
(1998)
Clin Neuropharmacolgy
, vol.21
, pp. 196-198
-
-
Garcia Ruiz, P.J.1
Cenjor Espanol, C.2
Sanchez Bernados, V.3
Astarloa, R.4
Sanabria, J.5
Garcia de Yebennes, J.6
-
4
-
-
0031925761
-
Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia
-
LANGEVELD TP, DROST HA, BAATENBURG DE JONG RJ. (1998). Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol, 107: 280-4.
-
(1998)
Ann Otol Rhinol Laryngol
, vol.107
, pp. 280-284
-
-
Langeveld, T.P.1
Drost, H.A.2
Baatenburg De Jong, R.J.3
-
5
-
-
0032441817
-
The effect of patient factors on response outcomes to Botox® treatment of spasmodic dysphonia J
-
LUNDY DS, LU FL, CASANIO RR, XUE JW. (1998). The effect of patient factors on response outcomes to Botox® treatment of spasmodic dysphonia J. Voice, 12: 460-6.
-
(1998)
Voice
, vol.12
, pp. 460-466
-
-
Lundy, D.S.1
Lu, F.L.2
Casanio, R.R.3
Xue, J.W.4
-
6
-
-
0026601716
-
Stridor and focal laryngeal dystonia
-
MARION MH, KLAP P, PERRIN A, COHEN M. (1992). Stridor and focal laryngeal dystonia, Lancet, 22: 457.
-
(1992)
Lancet
, vol.22
, pp. 457
-
-
Marion, M.H.1
Klap, P.2
Perrin, A.3
Cohen, M.4
-
7
-
-
0030721541
-
A comparison of methods of botulinum toxin injection for abductor spasmodic dysphonia
-
MELECA RJ, HOGIKYAN ND, BASTIAN RW. (1997). A comparison of methods of botulinum toxin injection for abductor spasmodic dysphonia. Otolaryngol. Head Neck Surg, 117: 487-92.
-
(1997)
Otolaryngol Head Neck Surg
, vol.117
, pp. 487-492
-
-
Meleca, R.J.1
Hogikyan, N.D.2
Bastian, R.W.3
-
8
-
-
0345698826
-
Supraglottal injection of botulinum toxin type A in adductor type spasmodic dysphonia with both intrinsic and extrinsic hyperfunction
-
SCHONWEILLER R, WOHLFARTH K, DENGLER R, PTOK M. (1998). Supraglottal injection of botulinum toxin type A in adductor type spasmodic dysphonia with both intrinsic and extrinsic hyperfunction. Laryngoscope, 108: 55-63.
-
(1998)
Laryngoscope
, vol.108
, pp. 55-63
-
-
Schonweiller, R.1
Wohlfarth, K.2
Dengler, R.3
Ptok, M.4
-
9
-
-
0031718211
-
Meta-analysis of botulinum toxin treatment of spasmodic dysphonia: A review of 22 studies
-
WHURR R, NYE C, LORCA M. (1998). Meta-analysis of botulinum toxin treatment of spasmodic dysphonia: a review of 22 studies. Int J Lang Commun Disord, 33: 327-9.
-
(1998)
Int J Lang Commun Disord
, vol.33
, pp. 327-329
-
-
Whurr, R.1
Nye, C.2
Lorca, M.3
|